A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Cumulative-dose, Dose-escalating, Three-arm, Cross-over Study, in 24 Asthma Patients.
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Amphastar Pharmaceuticals
- 27 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 27 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Sep 2010 New trial record